Search

Your search keyword '"de Seze, Jérôme"' showing total 689 results

Search Constraints

Start Over You searched for: Author "de Seze, Jérôme" Remove constraint Author: "de Seze, Jérôme"
689 results on '"de Seze, Jérôme"'

Search Results

1. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial

4. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).

5. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.

6. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

9. Diagnosis and classification of optic neuritis

11. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

14. COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France

15. Long-term Efficacy of Satralizumab in Patients with Aquaporin-4-IgG-seropositive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Updated Analysis from the Open-label SAkuraMoon Study (S32.002)

16. MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis

17. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

18. Myelin-oligodendrocyte glycoprotein antibody-associated disease

19. Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence

22. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease

23. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study

26. Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis

27. Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML

28. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France

30. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

32. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

38. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

39. The effect of oxysterols on nerve impulses

40. Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0)

41. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

44. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

45. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions

Catalog

Books, media, physical & digital resources